Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 3/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK1 | P23458 | 1/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | SPR | P35270 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22755031 | 0.89 | MGLL (0.35) | MGLLHSD11B1 | |
| SCHEMBL22754885 | 0.89 | HCRTR1 (0.35) | MGLLSLC6A9HSD11B1SPR | |
| SCHEMBL22729584 | 0.87 | DRD3 (0.35) | DRD3KCNH2MGLLSLC6A9TP53 | |
| SCHEMBL29839291 | 0.87 | DRD3 (0.35) | DRD3KCNH2MGLLSLC6A9TP53 | |
| SCHEMBL22754902 | 0.86 | SLC6A2 (0.36) | MGLLHSD11B1SPRMAPT | |
| SCHEMBL22755326 | 0.84 | MGLL (0.34) | MGLLP2RX7 | |
| SCHEMBL22755217 | 0.84 | MGLL (0.43) | DRD3KCNH2MGLLSLC6A9TP53 | |
| SCHEMBL22755344 | 0.82 | MGLL (0.47) | KCNH2MGLLHSD11B1SPR | |
| SCHEMBL22754986 | 0.81 | MGLL (0.37) | DRD3KCNH2MGLLHSD11B1 | |
| SCHEMBL22755016 | 0.81 | TSHR (0.34) | MGLLTP53MAPTP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3747885-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2020-12-09 | — | — | EP | disclosed |